Suchergebnisse - "Aoki, Daisuke"

PubPharm (27)

1

Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Kobayashi, Y. | Takeda, T. | Kunitomi, H. | +10

2

A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube or primary peritoneal cancer

enthalten in: Japanese journal of clinical oncology | 2021

von Nanki, Y. | Nomura, H. | Iwasa, N. | +9

3

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study

enthalten in: Cancer science | 2020

von Yoshihara, K. | Enomoto, T. | Aoki, D. | +8

4

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer : Subgroup analysis from the KEYNOTE-100

enthalten in: Cancer science | 2020

von Nishio, S. | Matsumoto, K. | Takehara, K. | +14

5

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer : CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2019

von Enomoto, T. | Aoki, D. | Hattori, K. | +7

6

Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation : A case report

enthalten in: Molecular and clinical oncology | 2018

von Takeda, T. | Banno, K. | Yanokura, M. | +11

7

GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy : a comprehensive analysis using targeted resequencing of 100 pharmacogenes

enthalten in: Oncotarget | 2018

von Yoshihama, T. | Fukunaga, K. | Hirasawa, A. | +6

8

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer

enthalten in: Oncotarget | 2017

von Hirasawa, A. | Imoto, I. | Naruto, T. | +7

9

Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer

enthalten in: Japanese journal of clinical oncology | 2017

von Yoshihama, T. | Nomura, H. | Iwasa, N. | +9

10

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer

enthalten in: Oncotarget | 2017

von Kobayashi, Y. | Kashima, H. | Rahmanto, Y. | +15